Fieldpoint Private Securities, LLC Fibrogen Inc Transaction History

Fieldpoint Private Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$18.57 - $35.68 $25,366 - $48,738	-1,366 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$31.0 - $55.72 $12,307 - $22,120	-397 Reduced 22.52%	1,366 $47,000
Q4 2020 Jan 28, 2021	BUY	$37.09 - $48.97 $65,389 - $86,334	1,763 New	1,763 $65,000
Q1 2020 May 11, 2020	SELL	$23.3 - $45.96 $122,604 - $241,841	-5,262 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$34.58 - $48.06 $111,727 - $155,281	3,231 Added 159.08%	5,262 $226,000
Q3 2019 Nov 07, 2019	SELL	$36.98 - $48.45 $6,471 - $8,478	-175 Reduced 7.93%	2,031 $75,000
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $77,496 - $122,499	2,206 New	2,206 $100,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.